President Donald Trump was treated Friday for COVID-19 with a high-dose of the experimental antibody drug developed by the US biotech firm Regeneron. What is
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok